Evidence map›Paper›PMID 42523931›Full record

ReviewResearch (Washington, D.C.)2026

Antimicrobial Nanozymes: Structure-Activity-Guided Design, Synergy, and Applications.

Yuan Liu, Kaili Guo, Jingnan Shi, Xiaoxiao Guo, Shiwei Luo, Lizeng Gao, Xiyun Yan, Ye Yuan, Bing Jiang

Abstract readReview
In one paragraph

Review in Research (Washington, D.C.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yuan LiuNanozyme Laboratory in Zhongyuan, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Kaili GuoNanozyme Laboratory in Zhongyuan, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Jingnan ShiNanozyme Laboratory in Zhongyuan, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Xiaoxiao GuoNanozyme Laboratory in Zhongyuan, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Shiwei LuoNanozyme Laboratory in Zhongyuan, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Lizeng GaoNanozyme Laboratory in Zhongyuan, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Xiyun YanNanozyme Laboratory in Zhongyuan, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Ye YuanNanozyme Laboratory in Zhongyuan, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Bing JiangNanozyme Laboratory in Zhongyuan, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, China.ORCID https://orcid.org/0000-0001-5389-3293

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanozymes are emerging as versatile antimicrobial agents to tackle drug-resistant infections and biofilm-associated persistence. In this review, we present an integrated framework that links natural enzyme-mediated host defense to the rational development of antimicrobial nanozymes, and summarize recent advances through a mechanism-materials-engineering-application pipeline. We first summarize representative bactericidal principles of natural enzymes to highlight bioinspired catalytic motifs relevant to nanozyme design. We then classify antibacterial nanozymes by catalytic reaction types, including oxidoreductase- and hydrolase-like activities, and by material platforms, highlighting structure-activity relationships that govern catalytic behavior and antimicrobial performance. Building on these mechanistic and structural insights, we summarize engineering-enhanced bactericidal modalities, including photothermal and photodynamic assistance, metal ion release, immune modulation, cascade catalysis, microenvironment-responsive regulation, and targeting, that help overcome constraints imposed by infectious microenvironments, such as hypoxia, limited hydrogen peroxide availability, elevated antioxidant levels, and biofilm barriers. Finally, we translate these principles into application-oriented guidance across interfaces ranging from abiotic surface protection, including antifouling and device coatings, to superficial and deep-seated infections, and we briefly discuss emerging nanozyme strategies for antifungal and antiviral interventions. Throughout, we emphasize translational considerations, such as activity benchmarking, biosafety evaluation, and scalable manufacturing, to support the development of clinically relevant antimicrobial nanozymes.

Identifiers

PMID42523931
PMCPMC13408278

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.